Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05351645 · ClinicalTrials.gov registry record · NA
Digital Narrative Bibliotherapy as a Scalable Intervention for Suicidal Thoughts
A NA study of Suicidal Ideation, sponsored by Harvard University.
- Completed
- Registry status
- NA
- Development phase
- 864
- Enrollment target
- 1
- Study location
NCT05351645: Completed NA study of Suicidal Ideation, sponsored by Harvard University.
NCT05351645 is a NA study of Suicidal Ideation that has completed, run by Harvard University. The registered enrollment target is 864 participants, above the 258-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (235% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05351645, a NA study of Suicidal Ideation, has completed, sponsored by Harvard University.
- COMPLETED
- Registry status
- NA
- Development phase
- 864 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study was to determine whether reading about others' experiences with suicide can help reduce suicidal thoughts. To investigate this issue, the investigators recruited users from an internet support community. The investigators randomized participants to two separate groups: a Treatment group and a Control group. Participants in the treatment group read one first-person narrative about suicide each day for 14 days, and answered questions before and after reading the narrative. Participants in the Control group answered questions once per day during the 14-day trial period and did not receive the narrative intervention until after the initial study ended. All participants completed a follow-up questionnaire two weeks after the end of the 14-day trial period.
Primary Outcome
Participants self-reported their current desire to die on a Likert-type scale. Responses were made using a 9-point Likert-type scale ranging from 1 (not at all) to 10 (definitely). Higher scores indicate higher feelings of suicidal thoughts.
Conditions Studied
Interventions
- BEHAVIORAL Treatment
Study Locations (1)
Massachusetts
- Harvard University - Cambridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 864 participants |
| Start Date | 2020-11-20 |
| Est. Completion | 2021-03-14 |
| Phase | NA |
What the finished NCT05351645 record still lists
NCT05351645 is an interventional study that assigns participants to a tested intervention. The registered 864 participants enrollment target is mid-sized for trials with a published cap, above the 258-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (235% higher).
The record links to 1 condition, with Suicidal Ideation appearing as the primary indexed condition, and to 1 intervention - of which Treatment is the first listed.
NCT05351645 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05351645 about?
NCT05351645 is a clinical study titled "Digital Narrative Bibliotherapy as a Scalable Intervention for Suicidal Thoughts". The goal of this study was to determine whether reading about others' experiences with suicide can help reduce suicidal thoughts. To investigate this issue, the investigators recruited users from an internet support community. The investigators randomized participants to two separate groups: a Treat...
What is the current status of trial NCT05351645?
This trial is currently completed. It is a NA study. The enrollment target is 864 participants. The study started on 2020-11-20. Estimated completion is 2021-03-14.
What conditions does trial NCT05351645 study?
This clinical trial studies the following conditions: Suicidal Ideation.
What interventions are being tested in trial NCT05351645?
The interventions under investigation include: Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT05351645?
This trial is sponsored by Harvard University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05351645 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicidal Ideation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05351645's enrollment target sits among peer trials
864 7th of 84 higher than 78 of 84 other Suicidal Ideation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
RECRUITING · NA
-
Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
-
Crisis Response Planning for Military Personnel
RECRUITING · NA
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06256588 · 864 participants · Phase 3
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- NCT06527794 · 864 participants · NA
Remote Hypertension Management for Black Patients
- NCT05369052 · 865 participants · Phase 3
Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)
- NCT05914116 · 862 participants · Phase 1
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI